Kelly Hill, MD
Sports Medicine · New Orleans, LANPI 1760914196
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,560 of the $9,094 with a category attached, or 83.1%. Smith+Nephew accounts for 90.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $4,090 and has fallen 83.8% since, to $662 in 2025.
Across 30 payments — averaging $303.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Stryker$678
- ALON Medical Technology$64
- Innovation Technologies Inc$54
- Heron Therapeutics, Inc.$43
- Bioventus LLC$19
- plus $28 from 2 others
What the payments were for
- Food & beverage$1,53417%
- Education$7,56083%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 9 | $8,207 |
| Stryker | 13 | $678 |
| ALON Medical Technology | 1 | $64 |
| Innovation Technologies Inc | 2 | $54 |
| Heron Therapeutics, Inc. | 2 | $43 |
| Bioventus LLC | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Vertex | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,094 in reported general payments places this provider in the 70th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 68 | $159 |
| Ibuprofen | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New Orleans
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brian GodshawNew Orleans$69K
- Paul PhillipsNew Orleans$26K
- Wendell HeardNew Orleans$17K
- Russell RussoNew Orleans$16K
- Scott MontgomeryNew Orleans$7K
- Brett CascioLake Charles$82K
- Andrew GottschalkJefferson$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.